To Compare Post Operative SensitivityNCT07765901
Comparison of Postoperative Sensitivity Following Bulk-Fill and Conventional Incremental Composite Restorations: This Study Will be Proceed at Tertiary Care Hospital of Peshawar
A study testing conventional incremental composite and bulk-fill composite in people with To Compare Post Operative Sensitivity, run by Prime Foundation.
Trial summary
When a dentist fills a cavity, regular filling material shrinks as it hardens and cannot be penetrated deeply by the curing light, forcing dentists to painstakingly apply it in tiny 2 mm layers to prevent it from pulling away from the tooth walls and creating gaps for bacteria. Read more about this study
- Who is it for?
- Ages 18 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- To Compare Post Operative Sensitivity
- What is being tested?
- conventional incremental composite and bulk-fill composite
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 220 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2027to 1 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Age of patient should range from 18-40 years.
- Teeth with class I carious lesion in maxillary and mandibular 1st and 2nd molar is included.
- The depth of cavity should be 4mm (with no sensitivity)
- Pulpal and periapical pathology should be absent confirmed through radiograph and clinical tests
Who cannot join
- The patient must not have any of the following Irreversible pulpitis Necrotic pulp Previous restoration in tooth Periodontically compromised tooth Painkiller history for past 1-2 days Not undergone crown cutting Bruxism or clenching habits Cracked tooth syndrome Pre-existing hypersensitivity Occlusal trauma
About this study
Official title: Comparison of Postoperative Sensitivity Following Bulk-Fill and Conventional Incremental Composite Restorations: A Randomized Controlled Trial at Tertiary Care Hospital of Peshawar
When a dentist fills a cavity, regular filling material shrinks as it hardens and cannot be penetrated deeply by the curing light, forcing dentists to painstakingly apply it in tiny 2 mm layers to prevent it from pulling away from the tooth walls and creating gaps for bacteria. To solve this, advanced "bulk-fill" composites were created; they are more see-through to let light reach the very bottom and contain flexible components that absorb their own shrinkage stress. This allows dentists to safely fill a deep 4 to 5 mm cavity all at once, saving significant time while still ensuring a tight, bacteria-proof seal.
- Conditions
- To Compare Post Operative Sensitivity
- Being tested
- conventional incremental composite, bulk-fill composite
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
conventional incremental compositeOther
Postoperative sensitivity following conventional incremental composite will be measured on follow-up after 1 week which will be done using the SCASS(Schiff cold air sensitivity
bulk-fill compositeOther
Postoperative sensitivity following bulk-fill composite will be measured on follow-up after 1 week which will be done using the SCASS(Schiff cold air sensitivity
| Study group | Role | What they receive |
|---|---|---|
| conventional incremental composite group | Experimental | Not described Receives: Other: conventional incremental composite |
| Bulk fill composite group | Experimental | Not described Receives: Other: bulk-fill composite |
What is being measured
The primary outcome is the main question the study is designed to answer.
postoperative sensitivity
Measured: 1 week after procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2026
- Study start1 Jan 2027 (estimated)
- Primary completion1 Jun 2027 (estimated)
- Study completion1 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for To Compare Post Operative SensitivityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 220 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Prime Foundation
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr. Fareeha Naz, Prime Foundation
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07765901
- Sponsor's protocol ID
- Prime Foundation Pak
- Status last verified
- Aug 2026
- First submitted
- 10 Aug 2026
- Last updated
- 21 Aug 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Postoperative Sensitivity Following Bulk-Fill and Conventional Incremental Composite Restorations: A Randomized Controlled Trial at Tertiary Care Hospital of Peshawar
- ClinicalTrials.gov ID
- NCT07765901
- Acronym / sponsor ID
- Prime Foundation Pak
- Conditions
- To Compare Post Operative Sensitivity
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 220 participants (estimated)
- Lead sponsor
- Prime FoundationUniversity, hospital or other
- Study start
- 1 Jan 2027 (estimated)
- Primary completion
- 1 Jun 2027 (estimated)
- Study completion
- 1 Jun 2027 (estimated)
- First posted
- 14 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
When a dentist fills a cavity, regular filling material shrinks as it hardens and cannot be penetrated deeply by the curing light, forcing dentists to painstakingly apply it in tiny 2 mm layers to prevent it from pulling away from the tooth walls and creating gaps for bacteria. To solve this, advanced "bulk-fill" composites were created; they are more see-through to let light reach the very bottom and contain flexible components that absorb their own shrinkage stress. This allows dentists to safely fill a deep 4 to 5 mm cavity all at once, saving significant time while still ensuring a tight, bacteria-proof seal.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| conventional incremental composite group | Experimental | Other: conventional incremental composite |
| Bulk fill composite group | Experimental | Other: bulk-fill composite |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Age of patient should range from 18-40 years.
- Teeth with class I carious lesion in maxillary and mandibular 1st and 2nd molar is included.
- The depth of cavity should be 4mm (with no sensitivity)
- Pulpal and periapical pathology should be absent confirmed through radiograph and clinical tests
Key exclusion criteria (1 listed)
- The patient must not have any of the following Irreversible pulpitis Necrotic pulp Previous restoration in tooth Periodontically compromised tooth Painkiller history for past 1-2 days Not undergone crown cutting Bruxism or clenching habits Cracked tooth syndrome Pre-existing hypersensitivity Occlusal trauma
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| conventional incremental compositePostoperative sensitivity following conventional incremental composite will be measured on follow-up after 1 week which will be done using the SCASS(Schiff cold air sensitivity | Other | conventional incremental composite group |
| bulk-fill compositePostoperative sensitivity following bulk-fill composite will be measured on follow-up after 1 week which will be done using the SCASS(Schiff cold air sensitivity | Other | Bulk fill composite group |
Primary outcome
postoperative sensitivity
Time frame: 1 week after procedure
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Aug 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing conventional incremental composite and bulk-fill composite in people with To Compare Post Operative Sensitivity, run by Prime Foundation.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
postoperative sensitivity (time frame: 1 week after procedure). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.